Multiple Sclerosis - Experts identify four clinical areas that are key to manage progressive multiple sclerosis
Can't see this email? View it online
   
  Multiple Sclerosis  
  The latest multiple sclerosis news from News Medical  
 An Introduction to AutoimmunityAn Introduction to Autoimmunity
 
Autoimmunity is a state when an individual’s immune system starts reacting against the body’s own normal components, producing disease.
 
   Experts identify four clinical areas that are key to manage progressive  multiple sclerosisExperts identify four clinical areas that are key to manage progressive multiple sclerosis
 
An international team of multiple sclerosis (MS) experts has identified four under-researched areas that are critical to advancing symptom management for progressive MS, recommending interdisciplinary collaboration among scientists, clinicians, industry leaders, and those with progressive MS.
 
   People with multiple sclerosis experience subtle language impairments, study showsPeople with multiple sclerosis experience subtle language impairments, study shows
 
Kessler Foundation researchers showed that people with multiple sclerosis (MS) experience subtle language impairments that standard neuropsychological tests may incorrectly attribute to impaired executive functions.
 
   Machine learning can monitor and predict the progression of multiple sclerosisMachine learning can monitor and predict the progression of multiple sclerosis
 
Monitoring the progression of multiple sclerosis-related gait issues can be challenging in adults over 50 years old, requiring a clinician to differentiate between problems related to MS and other age-related issues.
 
   Study: REAER is a promising therapy for improving the lives of patients with multiple sclerosisStudy: REAER is a promising therapy for improving the lives of patients with multiple sclerosis
 
A team of multiple sclerosis (MS) experts at Kessler Foundation led the first pilot randomized controlled trial of robotic-exoskeleton assisted exercise rehabilitation (REAER) effects on mobility, cognition, and brain connectivity in people with substantial MS-related disability.